MENU

IFRX InflaRx NV Forecast, Technical & Fundamental Analysis

a developer of biopharmaceutical products

Industry Biotechnology
IFRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
IFRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

IFRX is expected to report earnings to fall 22.50% to -23 cents per share on March 20

InflaRx NV IFRX Stock Earnings Reports
Q4'24
Est.
$-0.23
Q3'24
Missed
by $0.05
Q2'24
Missed
by $0.04
Q1'24
Beat
by $0.02
Q4'23
Missed
by $0.09
The last earnings report on November 08 showed earnings per share of -30 cents, missing the estimate of -25 cents. With 343.25K shares outstanding, the current market capitalization sits at 119.53M.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Winzerlaer Strasse 2
Phone
+49 3641508180
Employees
66
Web
https://www.inflarx.de
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

IFRX and Stocks

Correlation & Price change

A.I.dvisor tells us that IFRX and OMGA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IFRX and OMGA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IFRX
1D Price
Change %
IFRX100%
+18.71%
OMGA - IFRX
30%
Poorly correlated
-5.61%
PTGX - IFRX
30%
Poorly correlated
-3.82%
BEAM - IFRX
29%
Poorly correlated
-4.33%
AXSM - IFRX
28%
Poorly correlated
-0.47%
VTGN - IFRX
28%
Poorly correlated
-3.19%
More

Groups containing IFRX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IFRX
1D Price
Change %
IFRX100%
+18.71%
drugs
theme (254 stocks)
23%
Poorly correlated
-1.67%
biopharmaceuticals
theme (50 stocks)
23%
Poorly correlated
-2.60%
europe
theme (179 stocks)
9%
Poorly correlated
-0.09%
biotechnology
theme (238 stocks)
4%
Poorly correlated
-1.76%